Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 7Terminated 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 17Carcinoma, Renal Cell 14Neoplasms 12Neoplasm Metastasis 9Neuroendocrine Tumors 7Head and Neck Neoplasms 7Kidney Neoplasms 6Pancreatic Neoplasms 5Prostatic Neoplasms 4Lung Neoplasms 4Squamous Cell Carcinoma of Head and Neck 3Recurrence 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma 3Leukemia, Lymphocytic, Chronic, B-Cell 3Carcinoma, Non-Small-Cell Lung 3Carcinoma, Hepatocellular 3Waldenstrom Macroglobulinemia 2Urinary Bladder Neoplasms 2Triple Negative Breast Neoplasms 2Somatostatinoma 2Pheochromocytoma 2Paraganglioma 2Neuroectodermal Tumors, Primitive 2Lymphoma, T-Cell, Cutaneous 2Lymphoma, Non-Hodgkin 2Lymphoma, Mantle-Cell 2Lymphoma, Follicular 2Insulinoma 2Hodgkin Disease 2

Interventions

Temozolomide 17Radiotherapy 5Bevacizumab 5Filgrastim 4vocimagene amiretrorepvec 3sargramostim 3etoposide phosphate 3antineoplaston AS 2-1 3antineoplaston A10 3Surgical Procedures, Operative 3O(6)-benzylguanine 3Melphalan 3Lomustine 3Flucytosine 3Dynamic Contrast Enhanced Magnetic Resonance Imaging 3Carmustine 3Aminolevulinic Acid 32-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 3tovorafenib 2palbociclib 2cabozantinib 2Vorinostat 2Topotecan 2Thiotepa 2Radiotherapy, Intensity-Modulated 2Perfusion Magnetic Resonance Imaging 2Magnetic Resonance Spectroscopy 2Irinotecan 2Ifosfamide 2Granulocyte Colony-Stimulating Factor 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Astrocytoma × Everolimus × Clear all
NCT02023905 2022-12-29

Everolimus With and Without Temozolomide in Adult Low Grade Glioma

University of California, San Francisco

Phase 2 Terminated
27 enrolled 15 charts
CNS

Astrocytoma, Oligodendroglioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡